Avanir Sues Ranbaxy To Block Generic Nuedexta
Avanir Pharmaceuticals Inc. on Friday filed the latest in a series of suits alleging proposed generic versions of its neurological disorder drug Nuedexta would infringe two of its patents, this time...To view the full article, register now.
Already a subscriber? Click here to view full article